Sodium fluoride (Na18F) PET Response Criteria in Solid Tumors (NAFCIST): a framework for response assessment in bone tumors

Autor: Kairemo, K., Gouda, M.A., Buschhorn, L., Wahida, A., Macapinlac, H.A., Anderson, P.M., Subbiah, V.

Publikováno v: In ESMO Open August 2023 8(4)

Reimbursement in the Context of Precision Oncology Approaches in Metastatic Breast Cancer: Challenges and Experiences.

Autor: Pixberg C; Molecular Diagnostics Program, National Center for Tumor Diseases (NCT) Heidelberg, Heidelberg, Germany.; Division of Gynecological Oncology, National Center for Tumor Diseases (NCT), University of Heidelberg and German Cancer Research Center (DKFZ), Heidelberg, Germany., Schulze M; Molecular Diagnostics Program, National Center for Tumor Diseases (NCT) Heidelberg, Heidelberg, Germany.; Division of Molecular Genetics, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany., Buschhorn L; Molecular Diagnostics Program, National Center for Tumor Diseases (NCT) Heidelberg, Heidelberg, Germany.; Division of Gynecological Oncology, National Center for Tumor Diseases (NCT), University of Heidelberg and German Cancer Research Center (DKFZ), Heidelberg, Germany.; Division of Molecular Genetics, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany., Suppelna JP; Molecular Diagnostics Program, National Center for Tumor Diseases (NCT) Heidelberg, Heidelberg, Germany.; Division of Gynecological Oncology, National Center for Tumor Diseases (NCT), University of Heidelberg and German Cancer Research Center (DKFZ), Heidelberg, Germany.; Division of Molecular Genetics, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany., Mock A; Department of Medical Oncology, National Center for Tumor Diseases (NCT), University Hospital Heidelberg, Heidelberg, Germany.; Department of Translational Medical Oncology, NCT Heidelberg, DKFZ, Heidelberg, Germany., Hlevnjak M; Molecular Diagnostics Program, National Center for Tumor Diseases (NCT) Heidelberg, Heidelberg, Germany.; Division of Molecular Genetics, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany., Heublein S; Division of Gynecological Oncology, National Center for Tumor Diseases (NCT), University of Heidelberg and German Cancer Research Center (DKFZ), Heidelberg, Germany.; Department of Obstetrics and Gynecology, Medical School, University of Heidelberg, Heidelberg, Germany., Schumacher-Wulf E; Mamma Mia! Die Krebsmagazine, Cologne, Germany., Schneeweiss A; Division of Gynecological Oncology, National Center for Tumor Diseases (NCT), University of Heidelberg and German Cancer Research Center (DKFZ), Heidelberg, Germany.

Publikováno v: Breast care (Basel, Switzerland) [Breast Care (Basel)] 2024 Feb; Vol. 19 (1), pp. 10-17. Date of Electronic Publication: 2023 Sep 20.

Transcriptomic profiling does not refine mastocytosis diagnosis

Autor: Buschhorn L; Division of Molecular Genetics, German Cancer Research Center (DKFZ), Heidelberg, Germany; Division of Gynecological Oncology, National Center for Tumor Diseases (NCT), Heidelberg, Germany; Department of Internal Medicine III, School of Medicine, Technical University of Munich, Munich., Odoni DI; Bioinformatics and Omics Data Analytics, German Cancer Research Center, Heidelberg, Germany; Biomedical Informatics, Data Mining and Data Analytics, Augsburg University, Augsburg., Geuder J; Anthropology and Human Genomics, Faculty of Biology, Ludwig-Maximilians University, Martinsried., Odinius TO; Department of Internal Medicine III, School of Medicine, Technical University of Munich, Munich., Wagner CV; Department of Internal Medicine III, School of Medicine, Technical University of Munich, Munich., Jilg S; Department of Internal Medicine III, School of Medicine, Technical University of Munich, Munich, Germany; Onkologie Erding, Erding., Höckendorf U; Department of Internal Medicine III, School of Medicine, Technical University of Munich, Munich., Wahida A; Division of Molecular Genetics, German Cancer Research Center (DKFZ), Heidelberg, Germany; Division of Gynecological Oncology, National Center for Tumor Diseases (NCT), Heidelberg, Germany; Department of Internal Medicine III, School of Medicine, Technical University of Munich, Munich., Schlesner M; Bioinformatics and Omics Data Analytics, German Cancer Research Center, Heidelberg, Germany; Biomedical Informatics, Data Mining and Data Analytics, Augsburg University, Augsburg., Reiter A; Medical Department III for Hematology and Oncology, University Clinic Mannheim, Mannheim., Jawhar M; Medical Department III for Hematology and Oncology, University Clinic Mannheim, Mannheim., Jost PJ; Department of Internal Medicine III, School of Medicine, Technical University of Munich, Munich, Germany; Division of Clinical Oncology, Department of Internal Medicine, Medical University of Graz, Graz. philipp.jost@medunigraz.at.

Publikováno v: Haematologica [Haematologica] 2023 Nov 01; Vol. 108 (11), pp. 3125-3130. Date of Electronic Publication: 2023 Nov 01.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

[Breast-like cancer of unknown primary : Implications for radiological diagnostics].

Autor: Schneeweiss A; Sektion für Gynäkologische Onkologie, Nationales Centrum für Tumorerkrankungen (NCT), Heidelberg, Deutschland. Andreas.schneeweiss@med.uni-heidelberg.de., Buschhorn L; Sektion für Gynäkologische Onkologie, Nationales Centrum für Tumorerkrankungen (NCT), Heidelberg, Deutschland. lars.buschhorn@med.uni-heidelberg.de.

Publikováno v: Radiologie (Heidelberg, Germany) [Radiologie (Heidelb)] 2023 May; Vol. 63 (5), pp. 366-370. Date of Electronic Publication: 2023 Mar 28.